Methotrexate: Understanding the risk in psoriasis patients

References

• Collins P, Rogers S. The efficacy of methotrexate in psoriasis – A review of 40 cases. Clin Exp Dermatol. 1992; 17: 257–60
   PubMed Web of Science ®Google Scholar
• Haustein UF, Rytter M. Methotrexate in psoriasis: 26 years’ experience with low-dose long-term treatment. J Eur Acad Dermatol Venereol. 2000; 14: 382–8
   PubMed Web of Science ®Google Scholar
• Kremer JM. Methotrexate update. Scand J Rheumatol. 1996; 25: 341–4
   PubMed Web of Science ®Google Scholar
• Salaffi F, Manganelli P, Carotti M, Subiaco S, Lamanna G, Cervini C. Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: Report of five cases and review of the literature. Clin Rheumatol. 1997; 16: 296–304
   PubMed Web of Science ®Google Scholar
• Mazokopakis E, Katsogridakis K, Koutsopoulos A, Voloudaki A, Froudarakis M, Kritikos H, et al. Fatal methotrexate-induced pneumonitis in a psoriatic patient. Mil Med. 2004; 169: 298–300
   Google Scholar
• Clerc D, Brousse C, Mariette X, Bennet P, Bisson M. Cytomegalovirus pneumonia in a patient with rheumatoid arthritis treated with low dose methotrexate and prednisone. Ann Rheum Dis. 1991; 50: 67
   Google Scholar
• Lemense GP, Sahn SA. Opportunistic infection during treatment with low dose methotrexate. Am J Respir Crit Care Med. 1994; 150: 258–60
   PubMed Web of Science ®Google Scholar
• Berthelot JM, Maugars Y, Hamidou M, Chiffoleau A, Barrier J, Grolleau JY, et al. Pancytopenia and severe cytopenia induced by low-dose methotrexate. Eight case-reports and a review of one hundred cases from the literature (with twenty-four deaths). Rev Rhum Engl Ed 1995; 62((7-8):)477–86
   Google Scholar
• Ostor AJ, O'Gradaigh DR, Jenner JR. Methotrexate for rheumatoid arthritis: What should the patient be told?. Rheumatology (Oxford). 2003; 42: 1576–8
   Google Scholar
• Szanto E. Low-dose methotrexate treatment of rheumatoid arthritis; long-term observation of efficacy and safety. Clin Rheumatol. 1989; 8: 323–30
   Google Scholar
• Mariette X, Cazals-hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. Lymphomas in rheumatoid arthritis patients treated with methotrexate: A 3-year prospective study in France. Blood. 2002; 99: 3909–15
   PubMed Web of Science ®Google Scholar
• Sosin M, Handa S. Low dose methotrexate and bone marrow suppression. BMJ. 2003; 326: 266–7
   PubMed Web of Science ®Google Scholar
• Thaler SJ, Bailey EM. Case 14 – 1996 – A 66-year-old woman with toxic epidermal necrolysis and a fatal course. N Engl J Med. 1996; 334: 1254–61
   Google Scholar
• Gutierrez-Urena S, Molina JF, Garcia CO, Cuellar ML, Espinoza LR. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum. 1996; 39: 272–6
   PubMed Web of Science ®Google Scholar
• Kremer JM, Alarcon GS, Weinblatt ME, Kaymakcian MV, Macaluso M, Cannon GW, et al. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: A multicenter study with literature review. Arthritis Rheum. 1997; 40: 1829–37
   PubMed Web of Science ®Google Scholar
• Mayall B, Poggi G, Parkin JD. Neutropenia due to low-dose methotrexate therapy for psoriasis and rheumatoid arthritis may be fatal. Med J Aust. 1991; 155: 480–4
   PubMedGoogle Scholar
• Buchbinder R, Hall S, Sambrook PN, Champion GD, Harkness A, Lewis D, et al. Methotrexate therapy in rheumatoid arthritis: A life table review of 587 patients treated in community practice. J Rheumatol. 1993; 20: 639–44
   PubMed Web of Science ®Google Scholar
• Krebs S, Gibbons RB. Low-dose methotrexate as a risk factor for Pneumocystis carinii pneumonia. Mil Med. 1996; 161: 58–60
   PubMedGoogle Scholar
• Zachariae H, Sogaard H, Heickendorff L. Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies – a further 10-year follow-up. Dermatology. 1996; 192: 343–6
   PubMedGoogle Scholar
• Vallerand H, Cossart C, Milosevic D, Lavaud F, Leone J. Fatal pneumocystis pneumonia in asthmatic patient treated with methotrexate. Lancet. 1992; 339: 1551
   Google Scholar
• al-Awadhi A, Dale P, Mckendry RJ. Pancytopenia associated with low dose methotrexate therapy. A regional survey. J Rheumatol. 1993; 20: 1121–5
   PubMed Web of Science ®Google Scholar
• Wallace JR, Luchi M. Fatal cytomegalovirus pneumonia in a patient receiving corticosteroids and methotrexate for mixed connective tissue disease. South Med J. 1996; 89: 726–8
   Google Scholar
• Omdal R, Goransson L, Bergrem H. Fatal outcome of low-dose methotrexate therapy in rheumatoid arthritis. Clin Rheumatol. 1993; 12: 283–4
   Google Scholar
• Myllykangas-Luosujarvi R, Aho K, Isomaki H. Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. J Rheumatol. 1995; 22: 2214–17
   Google Scholar
• Bedrossian CW, Miller WC, Luna MA. Methotrexate-induced diffuse interstitial pulmonary fibrosis. South Med J. 1979; 72: 313–18
   PubMedGoogle Scholar
• Imokawa S, Colby TV, Leslie KO, Helmers RA. Methotrexate pneumonitis: Review of the literature and histopathological findings in nine patients. Eur Respir J. 2000; 15: 373–81
   PubMed Web of Science ®Google Scholar
• Van der Veen MJ, Dekker JJ, Dinant HJ, van Soesbergen RM, Bijlsma JW. Fatal pulmonary fibrosis complicating low dose methotrexate therapy for rheumatoid arthritis. J Rheumatol. 1995; 22: 1766–8
   PubMedGoogle Scholar
• Sweet JM, Holstege CP. Bone marrow failure from medication error: Diagnosis by history, not biopsy. Arch Intern Med. 2001; 161: 1911–12
   Google Scholar
• Mckenna KE, Burrows D. Pulmonary toxicity in a patient with psoriasis receiving methotrexate therapy. Clin Exp Dermatol. 2000; 25: 24–7
   Google Scholar
• Sostman HD, Matthay RA, Putman CE, Smith GJ. Methotrexate-induced pneumonitis. Medicine (Baltimore). 1976; 55: 371–88
   PubMed Web of Science ®Google Scholar
• Hilliquin P, Renoux M, Perrot S, Puechal X, Menkes CJ. Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis. Br J Rheumatol. 1996; 35: 441–5
   PubMedGoogle Scholar
• Gispen JG, Alarcon GS, Johnson JJ, Acton RT, Barger BO, Koopman WJ. Toxicity of methotrexate in rheumatoid arthritis. J Rheumatol. 1987; 14: 74–9
   PubMed Web of Science ®Google Scholar
• MacKinnon SK, Starkebaum G, Willkens RF. Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis. Semin Arthritis Rheum. 1985; 15: 119–26
   Google Scholar
• Stenger AA, Houtman PM, Bruyn GA, Eggink HF, Pasma HR. Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis. Scand J Rheumatol. 1994; 23: 51–3
   PubMed Web of Science ®Google Scholar
• Scully CJ, Anderson CJ, Cannon GW. Long-term methotrexate therapy for rheumatoid arthritis. Semin Arthritis Rheum. 1991; 20: 317–31
   PubMed Web of Science ®Google Scholar
• Shiroky JB, Frost A, Skelton JD, Haegert DG, Newkirk MM, Neville C. Complications of immunosuppression associated with weekly low dose methotrexate. J Rheumatol. 1991; 18: 1172–5
   PubMed Web of Science ®Google Scholar
• Kevat SG, Hill WR, Mccarthy PJ, Ahern MJ. Pancytopenia induced by low-dose methotrexate for rheumatoid arthritis. Aust N Z J Med. 1988; 18: 697–700
   PubMedGoogle Scholar
• Kremer JM. Safety, efficacy, and mortality in a long-term cohort of patients with rheumatoid arthritis taking methotrexate: Follow up after a mean of 13.3 years. Arthritis Rheum. 1997; 40: 984–5
   PubMedGoogle Scholar
• Cornelissen JJ, Bakker LJ, Van der Veen MJ, Rozenberg-Arska M, Bijlsma JW. Nocardia asteroides pneumonia complicating low dose methotrexate treatment of refractory rheumatoid arthritis. Ann Rheum Dis. 1991; 50: 642–4
   Google Scholar
• St Clair EW, Rice JR, Synderman R. Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis. Arch Intern Med. 1985; 145: 2035–8
   PubMedGoogle Scholar
• Newman ED, Harrington TM. Fatal methotrexate pneumonitis in rheumatoid arthritis. Arthritis Rheum. 1988; 31: 1585–6
   PubMedGoogle Scholar
• Arnett FC, Whelton JC, Zizic TM, Stevens MB. Methotrexate therapy in polymyositis. Ann Rheum Dis. 1973; 32: 536–46
   PubMed Web of Science ®Google Scholar
• Kohler S, Neumann J, Durk H, Saal J, Muller GA. [Pancytopenia during low-dose oral methotrexate therapy of psoriatic arthritis.] Dtsch Med. Wochenschr. 1989; 114: 1286–8
   Google Scholar
• Wyss E, Kuhn M, Luzi HP, Reinhart WH. [Fatal outcome of pneumocystis-carinii pneumonia under low-dose methotrexate and prednisone therapy for chronic rheumatoid arthritis. Case report and literature review.] Schweiz Rundsch Med Prax. 1994; 83: 449–52
   Google Scholar
• Bruyn GA, Essed CE, Houtman PM, Willemse FW. Fatal cardiac nodules in a patient with rheumatoid arthritis treated with low dose methotrexate. J Rheumatol. 1993; 20: 912–14
   Google Scholar
• Sharma A, Provenzale D, Mckusick A, Kaplan MM. Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis. Gastroenterology. 1994; 107: 266–70
   Google Scholar
• Roux N, Flipo RM, Cortet B, Lafitte JJ, Tonnel AB, Duquesnoy B, et al. Pneumocystis carinii pneumonia in rheumatoid arthritis patients treated with methotrexate. A report of two cases. Rev Rhum Engl Ed. 1996; 63: 453–6
   Google Scholar
• Elsasser S, Dalquen P, Soler M, Perruchoud AP. Methotrexate-induced pneumonitis: Appearance four weeks after discontinuation of treatment. Am Rev Respir Dis. 1989; 140: 1089–92
   Google Scholar
• Roth PE, Grosshans E, Bergoend H. [Psoriasis: Development and fatal complications.] Ann Dermatol. Venereol. 1991; 118: 97–105
   Google Scholar
• Doolittle GC, Simpson KM, Lindsley HB. Methotrexate-associated, early-onset pancytopenia in rheumatoid arthritis. Arch Intern Med. 1989; 149: 1430–1
   PubMedGoogle Scholar
• Flood DA, Chan CK, Pruzanski W. Pneumocystis carinii pneumonia associated with methotrexate therapy in rheumatoid arthritis. J Rheumatol. 1991; 18: 1254–6
   PubMedGoogle Scholar
• Wollner A, Mohle-boetani J, Lambert RE, Perruquet JL, Raffin TA, Mcguire JL. Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis. Thorax. 1991; 46: 205–7
   PubMedGoogle Scholar
• Bell MJ, Geddie WR, Gordon DA, Reynolds WJ. Pre-existing lung disease in patients with rheumatoid arthritis may predispose to methotrexate lung. Arthritis Rheum. 1987; 29: S75
   Google Scholar
• Matsushima H, Takayanagi N, Kawata I, Sakamoto T, Motegi M, Ubukata M, et al. [Two fatal cases of methotrexate-induced interstitial pneumonitis.] Nihon Kokyuki Gakkai. Zasshi. 2002; 40: 249–55
   Google Scholar
• Jeurissen ME, Boerbooms AM, van de Putte LB. Pancytopenia and methotrexate with trimethoprim-sulfamethoxazole. Ann Intern Med. 1989; 111: 261
   PubMedGoogle Scholar
• Shupack JL, Webster GF. Pancytopenia following low-dose oral methotrexate therapy for psoriasis. JAMA. 1988; 259: 3594–6
   PubMedGoogle Scholar
• Kazlow DW, Federgrun D, Kurtin S, Lebwohl MG. Cutaneous ulceration caused by methotrexate. J Am Acad Dermatol. 2003; 49((2 suppl case reports):)S197–8
   Google Scholar
• Landewe RB, van den Borne BE, Breedveld FC, Dijkmans BA. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet. 2000; 355: 1616–17
   PubMed Web of Science ®Google Scholar
• Bologna C, Picot MC, Jorgensen C, Viu P, Verdier R, Sany J. Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate. Ann Rheum Dis. 1997; 56: 97–102
   PubMed Web of Science ®Google Scholar
• Ebeo CT, Girish MR, Byrd RP, Roy TM, Mehta JB. Methotrexate-induced pulmonary lymphoma. Chest. 2003; 123: 2150–3
   PubMedGoogle Scholar
• Cleary AG, McDowell H, Sills JA. Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma. Arch Dis Child. 2002; 86: 47–9
   PubMed Web of Science ®Google Scholar
• Baird RD, van Zyl-Smit RN, Dilke T, Scott SE., Rassam SM. Spontaneous remission of low-grade B-cell non-Hodgkin's lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: Case report and review of the literature. Br J Haematol. 2002; 118: 567–8
   PubMed Web of Science ®Google Scholar
• Tang H, Neuberger J. Review article: Methotrexate in gastroenterology – dangerous villain or simply misunderstood?. Aliment Pharmacol Ther. 1996; 10: 851–8
   Google Scholar
• Psoriasis-liver-methotrexate interactions. Arch Dermatol. 1973; 108: 36–42
   PubMedGoogle Scholar
• Yeoh S, Siderov J. Methotrexate misadventure: A case for counseling. Rheumatology (Oxford). 2001; 40: 230–2
   Google Scholar